← Open Payments lookup

KEVA FOTHERGILL: Open Payments

NPI 1285793935 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,339 in 111 payments from 25 companies in 2025. Trend: 2023 $2,450 · 2024 $2,203 · 2025 $2,339

Food & beverage: $2,339
CompanyPaymentsAmount
Dexcom, Inc.21$255
Lilly USA, LLC5$242
Takeda Pharmaceuticals U.S.A., Inc.9$217
AstraZeneca Pharmaceuticals LP8$201
Bayer Healthcare Pharmaceuticals Inc.11$196
GlaxoSmithKline, LLC.13$192
Lundbeck LLC5$133
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$126
ABBVIE INC.6$110
Vanda Pharmaceuticals Inc.4$108

Products named: Dexcom G6 Transmitter, TRINTELLIX, Kerendia, TRELEGY ELLIPTA, REXULTI, FARXIGA, CAPLYTA, FANAPT.

Industry payments across CT — which companies pay providers there.